Home / Anti-infectives / Haemophilus Influenzae B, Purified Antigen Conjugated
ATC J07AG01 · Haemophilus Influenzae B Vaccines · updated 2 Nov 2026
Haemophilus Influenzae B, Purified Antigen Conjugated shortage
As of 2 Nov 2026, Haemophilus Influenzae B, Purified Antigen Conjugated has a reported shortage in 1 of the 16 countries we track (Sweden), covering 1 product from 1 company.
Is there a Haemophilus Influenzae B, Purified Antigen Conjugated shortage?
Yes. As of 2 Nov 2026, Haemophilus Influenzae B, Purified Antigen Conjugated is reported short in 1 of the 16 countries we track: Sweden. The earliest expected return is 31 Dec 2026 (Sweden).
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Sanofi SAN · Euronext Paris
Affected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Act-HIB Injektionsflaska + engångsspruta med injektionsnål, 1 x (I+II) | Sanofi Winthrop Industrie | 1 Sep 2026 | 31 Dec 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Haemophilus Influenzae B, Purified Antigen Conjugated shortage?
Yes. As of 2 Nov 2026, Haemophilus Influenzae B, Purified Antigen Conjugated is reported short in 1 of the 16 countries we track: Sweden. The earliest expected return is 31 Dec 2026 (Sweden).
When will Haemophilus Influenzae B, Purified Antigen Conjugated be back in stock?
Companies expect supply back from 31 Dec 2026 in Sweden; Sweden: 31 Dec 2026. These are company estimates reported to each authority.
Why is Haemophilus Influenzae B, Purified Antigen Conjugated in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Haemophilus Influenzae B, Purified Antigen Conjugated shortages?
Sanofi.